{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:16:27Z","timestamp":1780103787311,"version":"3.54.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087997","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T22:03:08Z","timestamp":1392328988000},"page":"e87997","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia"],"prefix":"10.1371","volume":"9","author":[{"given":"Emmanouil","family":"Rizos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda A.","family":"Papathanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota G.","family":"Michalopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Laskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Mazioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kastania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Vasilopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Nikolaidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalabos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Liappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"F Angelucci","year":"2005","journal-title":"Mol Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.01.025","article-title":"Neurotrophins and schizophrenia","volume":"94","author":"PF Buckley","year":"2007","journal-title":"Schizophr Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/YCO.0b013e3283436eb7","article-title":"Brain-derived neurotrophic factor: findings in schizophrenia","volume":"24","author":"PF Buckley","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fpsyt.2013.00045","article-title":"BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory","volume":"4","author":"R Nieto","year":"2013","journal-title":"Front Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.schres.2011.03.011","article-title":"Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients","volume":"129","author":"EN Rizos","year":"2011","journal-title":"Schizophr Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/15622970802182733","article-title":"Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics","volume":"11","author":"EN Rizos","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"F Angelucci","year":"2000","journal-title":"J Neurosci Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"RW Grillo","year":"2007","journal-title":"J Psychiatr Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2011.01.039","article-title":"Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation","volume":"491","author":"M Pedrini","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.02.054","article-title":"Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics","volume":"382","author":"YL Tan","year":"2005","journal-title":"Neurosci Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"S Pirildar","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.pnpbp.2007.03.010","article-title":"Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients","volume":"31","author":"R Yoshimura","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref13","first-page":"21","article-title":"Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients","volume":"22","author":"H Hori","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2005.11.021","article-title":"Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus","volume":"82","author":"A Pillai","year":"2006","journal-title":"Schizophr Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psychres.2011.01.011","article-title":"Effects of antipsychotics on the serum BDNF levels in schizophrenia","volume":"189","author":"CC Chen","year":"2011","journal-title":"Psychiatry Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.04.001","article-title":"Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder","volume":"420","author":"CS Gama","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/appi.ajp.2010.09081187","article-title":"The hippocampal formation in schizophrenia","volume":"167","author":"CA Tamminga","year":"2010","journal-title":"Am J Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresrev.2006.12.008","article-title":"Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia","volume":"54","author":"P Boyer","year":"2007","journal-title":"Brain Res Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2011.06.007","article-title":"Hippocampal interneurons are abnormal in schizophrenia","volume":"131","author":"C Konradi","year":"2011","journal-title":"Schizophr Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0925-4927(02)00025-2","article-title":"Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data","volume":"115","author":"ME Shenton","year":"2002","journal-title":"Psychiatry Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archpsyc.55.5.433","article-title":"Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study","volume":"55","author":"MD Nelson","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1073858410395147","article-title":"Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis","volume":"18","author":"F Adriano","year":"2012","journal-title":"Neuroscientist"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1176\/jnp.2009.21.1.24","article-title":"Hippocampal volumes in first-episode psychosis","volume":"21","author":"S Verma","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/344339a0","article-title":"Identification and characterization of a novel member of the nerve growth factor\/brain-derived neurotrophic factor family","volume":"344","author":"A Hohn","year":"1990","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.modgep.2006.03.009","article-title":"BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan","volume":"6","author":"MJ Webster","year":"2006","journal-title":"Gene Expr Patterns"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.63.2.139","article-title":"Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals","volume":"63","author":"D Velakoulis","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fpsyt.2012.00096","article-title":"Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness","volume":"3","author":"D Mamah","year":"2012","journal-title":"Front Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1461145710000817","article-title":"Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms","volume":"14","author":"BH Ebdrup","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","article-title":"Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies","volume":"188","author":"RG Steen","year":"2006","journal-title":"Br J Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.schres.2008.06.023","article-title":"Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study","volume":"104","author":"EM Meisenzahl","year":"2008","journal-title":"Schizophr Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2011.11.012","article-title":"An MRI study of septi pellucidi in relation to hippocampus volume and fornix integrity in schizophrenia","volume":"134","author":"CA Davidson","year":"2012","journal-title":"Schizophr Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0925-4927(97)00012-7","article-title":"Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia","volume":"74","author":"LE DeLisi","year":"1997","journal-title":"Psychiatry Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"BC Ho","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"SW Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/brain\/115.4.1001","article-title":"Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy","volume":"4)","author":"MJ Cook","year":"1992","journal-title":"Brain 115 (Pt"},{"key":"ref36","first-page":"637","article-title":"Methods for normalization of hippocampal volumes measured with MR","volume":"16","author":"SL Free","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref37","unstructured":"SPSS I Bootstrap 20 User\u2019s Guide."},{"key":"ref38","unstructured":"ACD DVH (2006) Bootstrap Methods and their Application."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1214\/08-STS273","article-title":"Accurate Parametric Inference for Small Samples","volume":"23","author":"B R.Alessandra","year":"2008","journal-title":"Statistical Science"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e55783","DOI":"10.1371\/journal.pone.0055783","article-title":"Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia","volume":"8","author":"T Colibazzi","year":"2013","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1038\/tp.2012.116","article-title":"Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies","volume":"2","author":"A Vita","year":"2012","journal-title":"Transl Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","article-title":"Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs","volume":"151","author":"MH Chakos","year":"1994","journal-title":"Am J Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"J Lieberman","year":"2001","journal-title":"Biol Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"JA Lieberman","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"JA Lieberman","year":"2008","journal-title":"Pharmacol Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"CG Wakade","year":"2002","journal-title":"J Neurosci Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"O Bai","year":"2003","journal-title":"J Neurosci Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e58607","DOI":"10.1371\/journal.pone.0058607","article-title":"Development of antipsychotic medications with novel mechanisms of action based on computational modeling of hippocampal neuropathology","volume":"8","author":"PJ Siekmeier","year":"2013","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4088\/JCP.08m04574yel","article-title":"Hippocampal volume change in schizophrenia","volume":"71","author":"PC Koolschijn","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1192\/bjp.186.1.26","article-title":"Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia","volume":"186","author":"MH Chakos","year":"2005","journal-title":"Br J Psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pscychresns.2006.04.008","article-title":"Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment","volume":"148","author":"RK McClure","year":"2006","journal-title":"Psychiatry Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.schres.2007.05.002","article-title":"A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia","volume":"94","author":"WJ Panenka","year":"2007","journal-title":"Schizophr Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2006.05.028","article-title":"Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients","volume":"86","author":"A Palomino","year":"2006","journal-title":"Schizophr Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jpsychires.2006.08.007","article-title":"Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics","volume":"41","author":"XY Zhang","year":"2007","journal-title":"J Psychiatr Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.pnpbp.2008.04.007","article-title":"Investigation of serum BDNF levels in drug-naive patients with schizophrenia","volume":"32","author":"EN Rizos","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.pnpbp.2009.08.011","article-title":"Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics","volume":"33","author":"MH Xiu","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2008.05.022","article-title":"Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia","volume":"439","author":"HJ Reis","year":"2008","journal-title":"Neurosci Lett"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"351","author":"E Shimizu","year":"2003","journal-title":"Neurosci Lett"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpsychires.2005.11.004","article-title":"Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients","volume":"40","author":"TL Huang","year":"2006","journal-title":"J Psychiatr Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2009.02.017","article-title":"Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia","volume":"66","author":"S Vinogradov","year":"2009","journal-title":"Biol Psychiatry"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/sj.npp.1301619","article-title":"BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia","volume":"33","author":"XY Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"W Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"F Karege","year":"2002","journal-title":"Neurosci Lett"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","article-title":"Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats","volume":"42","author":"A Sartorius","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874241601205010007","article-title":"Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF) and Its Precursor proBDNF in Healthy Subjects","volume":"5","author":"T Yoshida","year":"2012","journal-title":"Open Clin Chem J"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e42676","DOI":"10.1371\/journal.pone.0042676","article-title":"Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder","volume":"7","author":"T Yoshida","year":"2012","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:10:42Z","timestamp":1540347042000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087997"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087997","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}